Coagulation Factor Viii Concentrate Tender in Poland - 146645229

Procurement Summary

Country: Poland

Summary: Coagulation Factor Viii Concentrate (Plasma-Derived or Recombinant) with Delivery to Regional Blood Donation and Blood Treatment Centers. Parts 1-5; Reference Number: Zzp.Zp.411.123.2026

Deadline: 07 Sep 2026

Posting Date: 06 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 146645229

Document Ref. No.: 543914-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33621000 - Medicinal products for the blood and blood-forming organs

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Part 1. Coagulation factor VIII concentrate (plasma-derived or recombinant) with delivery to Regional Blood Donation and Blood Treatment Centers. Part 2. Coagulation factor VIII concentrate (plasma-derived or recombinant) with delivery to Regional Blood Donation and Blood Treatment Centers. Part 3. Coagulation factor VIII concentrate (plasma-derived or recombinant) with delivery to Regional Blood Donation and Blood Treatment Centers. Part 4. Coagulation factor VIII concentrate (plasma-derived or recombinant) with delivery to Regional Blood Donation and Blood Treatment Centers. Part 5. Coagulation factor VIII concentrate (plasma-derived or recombinant) with delivery to Regional Blood Donation Centers and Blood therapy. The subject of the order is the supply of coagulation factor VIII concentrate (plasma-derived or recombinant) to ensure the continuity of treatment of patients with hemophilia A - hereinafter referred to as "coagulation factor", with availability category Rp or Rpz, to the Regional Blood Donation and Blood Treatment Centers (hereinafter referred to as RCKiK) indicated by the National Blood Center (hereinafter referred to as NCK), on the terms specified in this SWZ. 1. The subject of the order is the supply of coagulation factor VIII concentrate (plasma-derived or recombinant) to ensure the continuity of treatment of patients with hemophilia A - hereinafter referred to as "coagulation factor", with the availability category Rp or Rpz, to those indicated by the National Blood Center (hereinafter NCK)...
Document Type: Contract Notice Reference Number: ZZP.ZP.411.123.2026 Contract Type: supplies Authority Type: cga Doc Title: Coagulation factor VIII concentrate (plasma-derived or recombinant) with delivery to Regional Blood Donation Centers and Blood therapy. Parts 1-5; reference number: ZZP.ZP.411.123.2026 Dispatch Date: 2026-08-05 Publish Date: 2026-08-06 Submission Date: 2026-09-07

Documents

 Tender Notice